Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Shares Issued (2021 - 2025)

iSpecimen has reported Shares Issued over the past 5 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Shares Issued at $2.2 million for Q4 2025, up 305.26% from a year ago — trailing twelve months through Dec 2025 was $2.9 million (up 629.02% YoY), and the annual figure for FY2025 was $4.0 million, up 903.8%.
  • Shares Issued for Q4 2025 was $2.2 million at iSpecimen, up from $1.8 million in the prior quarter.
  • Over the last five years, Shares Issued for ISPC hit a ceiling of $2.2 million in Q4 2025 and a floor of -$15.5 million in Q3 2021.
  • Median Shares Issued over the past 5 years was $3153.0 (2023), compared with a mean of -$1.0 million.
  • Biggest five-year swings in Shares Issued: decreased 10.02% in 2023 and later surged 42904.35% in 2024.
  • iSpecimen's Shares Issued stood at -$2.5 million in 2021, then surged by 100.01% to $254.0 in 2022, then skyrocketed by 1141.34% to $3153.0 in 2023, then plummeted by 34859.66% to -$1.1 million in 2024, then skyrocketed by 305.26% to $2.2 million in 2025.
  • The last three reported values for Shares Issued were $2.2 million (Q4 2025), $1.8 million (Q3 2025), and -$1.1 million (Q4 2024) per Business Quant data.